showed a trendp < 0.021
Glycine levels determined by relative quantification showed a trend of higher levels in HER-2 pos compared to HER-2 neg tumors in the different ER and PgR status groups (p < 0.021 and q < 0.133 ).
Glycine levels determined by relative quantification showed a trend of higher levels in HER-2 pos compared to HER-2 neg tumors in the different ER and PgR status groups (p < 0.021 and q < 0.133 ).